Does being a 503A vs 503B facility change GLP-1 insurance?

Yes - the 503A vs 503B distinction materially changes the program because it changes the scale, the regulation, and the products exposure. A 503A compounding pharmacy compounds pursuant to individual prescriptions and is regulated primarily at the state board level; a 503B outsourcing facility registers with FDA, follows cGMP, and can compound at larger scale without patient-specific prescriptions. The 503B model looks more like a manufacturer.

That flows into the insurance. A 503A GLP-1 pharmacy runs a program built around druggist and professional liability, products, sterile-peril property, crime, and cyber. A 503B GLP-1 outsourcing facility carries a larger products tower, cGMP-oriented property with validation and reprocessing, and recall coverage sized to manufacturer-scale distribution, and it faces sponsor-contract and hospital-contract insurance requirements.

Both face the GLP-1 scrutiny, but the 503B's larger scale and manufacturer-like exposure generally push its limits and premium higher. Confirming the facility's status is the first step in structuring the program.